
Excellent
BPC-157 + TB-500
The BPC-157 + TB-500 stack accelerates recovery, enhances tissue repair, and supports faster healing and mobility after injury or physical strain.
- Accelerates healing & recovery
- Reduces inflammation & pain
- Promotes muscle growth & flexibility
- Strengthens gut, tendon & connective tissue health
* Price reflects a 6-month treatment plan
This advanced combination pairs two peptides that work synergistically to stimulate cellular regeneration and reduce inflammation. BPC-157 targets the gut-brain axis and vascular pathways to promote tissue repair and angiogenesis, while TB-500 (Thymosin Beta-4) enhances cell migration and blood vessel growth in damaged areas. Together, they help the body repair soft tissue, tendons, and muscle more efficiently making recovery from workouts or injuries faster and more complete.
BPC-157 was first isolated from gastric proteins in the early 1990s and has since been extensively studied in animal models for its wound-healing and anti-inflammatory properties. TB-500, a synthetic form of the naturally occurring Thymosin Beta-4 peptide discovered in the 1980s, has been shown to enhance cellular movement and regeneration. Early research suggests that combining the two may produce additive effects accelerating angiogenesis, reducing inflammation, and supporting connective-tissue remodeling beyond what either peptide achieves alone.
Reported side effects are rare but may include mild injection-site irritation, temporary fatigue, or dizziness.
See the Science
The studies shown below reference Thymosin Beta-4 (TB-500) alone, a compound AIRA does not offer as a standalone therapy, but rather as part of a stacked formulation with BPC-157. To explore detailed research and product information on BPC-157, please visit that dedicated product page.
Histological Evaluation of the Effect of Thymosin β₄ on Wound Healing of Skin2024
Thymosin β₄ and Prothymosin α Promote Cardiac Regeneration in Adult Mammals2023
Local and Systemic Peptide Therapies for Soft-Tissue Regeneration2024
Thymosin β₄ Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals2025
Key Takeaways
Recovery-Focused Peptide
Performance-Medicine Interest
Supports Cell Migration
Angiogenesis Promotion
Frequently asked questions
Neither BPC-157 or TB-500 has been approved by the U.S. Food and Drug Administration. They can only be prescribed through licensed clinicians where state law allows.
Human data are still limited, but animal and early cellular studies suggest these peptides may accelerate soft-tissue repair and support recovery.
Together, BPC-157 and TB-500 appear to stimulate blood-flow and cellular repair, supporting tendon, ligament, and muscle recovery while helping the body reduce inflammation and promote healing.
Both peptides have shown strong safety profiles in preclinical studies. The most common effect is mild injection-site irritation.
Competitive athletes (subject to anti-doping rules), pregnant or breastfeeding individuals, and those with certain medical conditions should consult their doctor before use.
Both peptides are usually administered via subcutaneous injection, typically in the abdomen.
Yes, some clinics also pair this combination with peptides like CJC-1295 + Ipamorelin to support muscle growth, recovery, or performance pathways. Any stack should be clinician-supervised.
How AIRA works
Medical Intake
Prescription
Delivery
Why AIRA?
Your body already holds the blueprint — AIRA helps you unlock it. Our physician-guided peptide programs will help you perform, recover, and feel your best.
Start your new AIRA today
Unleash a healthier, more energetic version of yourself with AIRA. Check out treatments now and embark on your journey to a fulfilling life.

